Researchers from the Queensland University of Technology conducted a review of 26 international studies and found that healthcare professionals require more information about medicinal cannabis before they start prescribing it to patients. Read the article here.
In the first 12 months we expect to see two tonnes plus in export. Exportation will begin to Germany, where we have signed a 10-year supply contract with Cannamedical Pharma.
The latest national survey from Chronic Pain Australia found that more than a third of respondents said, after discussing medicinal cannabis as a pain treatment with their GP that they faced difficulty when it came around to the approval process.
As a response to more than 10,000 prescriptions for medicinal cannabis that have been written in Australia so far, The Morrison government is planning on prioritising new licences for projects granted “major project status” by the industry department.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >